home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events   |   Search    |   Write an announcement  
 

Meetings and Conferences by date

 
  November, 10 2026
your calendar for events in genetics, biotechnology and medicine
 
 
November 2026 2026-11-09
Cancer Research: As oncology research continues to advance, understanding the clinical significance of emerging evidence is essential for informing treatment strategies and guiding future research. The European Societ
Xtalks — The Life Science Community™, Online webinar
  2026-11-09
Others: Liquid biopsy has made it possible to detect and characterize cancer from a blood sample, with much of the field focused on circulating tumor DNA (ctDNA). Detection in early-stage disease remains chal
Xtalks — The Life Science Community™, Online webinar
  2026-11-09
Microbiology / Virology: The diabetes clinical trial landscape is evolving rapidly. As type 1 diabetes programs expand and innovative therapies, including cell and gene therapies, move into clinical development, sponsors face
Xtalks — The Life Science Community™, Online webinar
  2026-11-10
Microbiology / Virology: For neurodegenerative disease clinical trials, understanding how a condition is progressing and whether a treatment is having an effect can be difficult using traditional assessments alone. Biomarker
Xtalks — The Life Science Community™, Online webinar
  2026-11-10
Others: Early-phase neuroscience trials have traditionally focused primarily on establishing safety and tolerability. From Alzheimer's disease to psychiatry, early development strategies can also generate mea
Xtalks — The Life Science Community™, Online webinar
  2026-11-11
Others: As the biologics landscape becomes increasingly complex and therapeutic modalities grow more sophisticated, potency assay strategies are evolving from regulatory requirements into powerful tools that
Xtalks — The Life Science Community™, Online webinar
  2026-11-11
Others: Validation programs often experience delays not because of technical challenges, but because documentation gaps can create uncertainty, rework and misalignment across teams. Effective documentation pr
Xtalks — The Life Science Community™, Online webinar
  2026-11-12
Microbiology / Virology: Cell and gene therapies (CGTs) present unique development challenges, from novel manufacturing processes and delivery methods to complex nonclinical programs and evolving regulatory expectations. For
Xtalks — The Life Science Community™, Online webinar
  2026-11-12
Others: Psychiatric drug development still leans on rating scales developed decades ago: subjective instruments that capture how a patient describes feeling but not what the brain is doing. In major depressiv
Xtalks — The Life Science Community™, Online webinar
  2026-11-12
Others: Enzyme replacement therapies have transformed the treatment landscape for many rare genetic and metabolic disorders by addressing enzyme deficiencies that drive disease progression. By supplying a fun
Xtalks — The Life Science Community™, Online webinar
  2026-11-16
Microbiology / Virology: Executing clinical trials in complex glomerular diseases require moving beyond traditional functional involvement. As treatment paradigms and regulatory expectations for surrogate endpoints evolve, in
Xtalks — The Life Science Community™, Online webinar
  2026-11-17
Others: As biopharmaceutical programs advance under increasingly compressed timelines, upstream development teams face pressure to deliver optimized, quality-targeted processes earlier. Early decisions still
Xtalks — The Life Science Community™, Online webinar
  2026-11-17
Microbiology / Virology: Therapeutic antibodies are a rapidly growing class of drugs. Their application areas are not only limited to the standard immunoglobulin G (IgG) format but can also be extended to novel formats, inclu
Xtalks — The Life Science Community™, Online webinar
  2026-11-17
Others: Early-phase clinical trials operate under compressed timelines, complex protocols, narrow eligibility criteria and limited patient populations, making even small delays disproportionately costly. For
Xtalks — The Life Science Community™, Online webinar
  2026-11-18
Others: Successful biologics programs depend on making the right decisions at the right stage of development. Early choices in cell culture strategy, media and feed optimization, downstream recovery, analytic
Xtalks — The Life Science Community™, Online webinar
  2026-11-18
Others: When it comes to advanced therapies, expanding globally involves more than establishing additional sites or capabilities. Transitioning to multisite clinical trials or preparing for commercialization
Xtalks — The Life Science Community™, Online webinar
  2026-11-19
Microbiology / Virology: Early-stage oncology development is increasingly global. For emerging biopharma, the goal is not simply to expand into more countries, but to build a development strategy that identifies the right mar
Xtalks — The Life Science Community™, Online webinar
  2026-11-19
Others: Artificial Intelligence (AI) is rapidly transforming biometrics functions across the clinical trial lifecycle, from protocol design and statistical analysis planning to programming, data standardizati
Xtalks — The Life Science Community™, Online webinar
  2026-11-23
Others: Life sciences small and medium-sized enterprises (SMEs) need to make high-stakes R&D decisions quickly, from understanding disease biology and validating biomarkers to identifying meaningful patient p
Xtalks — The Life Science Community™, Online webinar
  2026-11-24
Others: Reliable capsid titer measurement is one of the most critical analytical requirements in AAV gene therapy development. However, moving a titer assay from development to a GMP-regulated quality control
Xtalks — The Life Science Community™, Online webinar
  2026-11-26
Others: Lyophilization has become an important development and commercialization strategy for modern parenteral products, including biologics, antibody-drug conjugates, mRNA-lipid nanoparticles, viral vectors
Xtalks — The Life Science Community™, Online webinar
 
December 2026 2026-12-01
Others: GxP internal audits often require quality teams across the life sciences industry to balance the depth of their assessments with the need for comprehensive coverage. Traditional approaches may involve
Xtalks — The Life Science Community™, Online webinar
  2026-12-01
Neurology / Neuroscience: Neuroscience clinical development is evolving across Alzheimer’s disease, Parkinson’s disease, psychiatry and other complex CNS disorders. Disease heterogeneity, trial accessibility, endpoint selectio
Xtalks — The Life Science Community™, Online webinar
  2026-12-02
Others: Applied AI and electronic health records (EHR) can strengthen patient recruitment by improving patient identification and providing clinical trial sites with a consolidated view of candidate eligibili
Xtalks — The Life Science Community™, Online webinar
  2026-12-02
Microbiology / Virology: Thrombolysis and thrombectomy have transformed acute ischemic stroke care, yet the need for therapies that improve recovery and reduce disability remains. For small and mid-sized biotech companies dev
Xtalks — The Life Science Community™, Online webinar
  2026-12-02
Cell and Molecular Biology / Anatomy: Super-resolution imaging can reveal biological detail that conventional confocal microscopy cannot resolve, but many workflows still force researchers to choose between resolution, speed, multicolor c
Xtalks — The Life Science Community™, Online webinar
  2026-12-03
Pharmacogenetics / Pharmacogenomics: Understanding who the right patients are and how to find them remains a challenge across the therapy lifecycle. From clinical development and trial enrollment through post-approval, each stage generat
Xtalks — The Life Science Community™, Online webinar
  2026-12-03
Others: Central nervous system (CNS) research presents unique challenges, requiring the capture of multiple types and formats of data from clinicians, patients, caregivers and performance-based assessments. T
Xtalks — The Life Science Community™, Online webinar
  2026-12-04
Microbiology / Virology: Cell and gene therapy programs bring together scientific innovation and clinical complexity unlike many traditional drug development programs. From selecting meaningful biomarkers and designing fit-fo
Xtalks — The Life Science Community™, Online webinar
  2026-12-04
Others: Serialization has helped pharmaceutical packaging lines meet compliance requirements, but it has also introduced operational challenges for many manufacturers and CMOs. Codes that fail to meet grading
Xtalks — The Life Science Community™, Online webinar
  2026-12-07
Microbiology / Virology: Next-generation immunotherapies create interconnected CMC, nonclinical, clinical and regulatory challenges. If key decisions around potency, comparability, model relevance, biomarkers and first-in-hum
Xtalks — The Life Science Community™, Online webinar
  2026-12-07
Others: There is growing pressure for therapeutics to demonstrate meaningful health benefits beyond the traditional weight loss efficacy metrics. For example, body composition assessments are increasingly use
Xtalks — The Life Science Community™, Online webinar
  2026-12-08
Others: As Alzheimer's disease (AD) clinical trials are conducted earlier in the disease continuum, efficient approaches to identify appropriate participants are increasingly important. While biomarkers remai
Xtalks — The Life Science Community™, Online webinar
  2026-12-09
Others: An efficient transition from drug discovery to first-in-human studies requires highly productive clones with the right product quality, scalable processes and rapid process development toward robust G
Xtalks — The Life Science Community™, Online webinar
  2026-12-09
Microbiology / Virology: Cardiovascular trials are becoming harder to execute. Patient populations increasingly overlap across competing studies and sponsors who rely on the same historically top-performing sites face diminis
Xtalks — The Life Science Community™, Online webinar
  2026-12-09
Others: Predicting whether a therapeutic protein can be manufactured and formulated successfully typically requires a dedicated experimental campaign for each molecular format. However, the ability to apply e
Xtalks — The Life Science Community™, Online webinar
  2026-12-10
Microbiology / Virology: Inflammatory skin diseases such as psoriasis, hidradenitis suppurativa and atopic dermatitis extend beyond the skin, with growing evidence linking these conditions to obesity, metabolic dysfunction, s
Xtalks — The Life Science Community™, Online webinar
  2026-12-10
Others: As nucleic acid therapeutics advance, researchers increasingly need tools that provide more than confirmation of target engagement or tissue exposure. Understanding the localization and distribution o
Xtalks — The Life Science Community™, Online webinar
  2026-12-10
Others: As nucleic acid therapeutics advance, researchers increasingly need tools that provide more than confirmation of target engagement or tissue exposure. Understanding the localization and distribution o
Xtalks — The Life Science Community™, Online webinar
  2026-12-11
Others: Targeted alpha therapies are emerging as a promising area of radiopharmaceutical development, delivering high-potency, short-range radiation designed to target cancer cells while limiting damage to su
Xtalks — The Life Science Community™, Online webinar
  2026-12-11
Others: Regulators increasingly want to see the patient voice included to inform drug development and qualitative in-trial patient interviews provide valuable insights into patient experiences that can suppor
Xtalks — The Life Science Community™, Online webinar
  2026-12-11
Others: Despite rapid advances in precision medicine and biomarkers, translating scientific progress into effective oncology research remains challenging. Access to molecular testing, study eligibility, resea
Xtalks — The Life Science Community™, Online webinar
  2026-12-14
Microbiology / Virology: This webinar is the second in a four-part series from Bioculture and EARA examining the science, regulation and responsibility behind the use of non-human primates (NHPs) in biomedical research. The s
Xtalks — The Life Science Community™, Online webinar
  2026-12-14
Others: The shift towards home healthcare is transforming the medical device industry. Driven by ageing populations, the growth of remote patient monitoring and increasing demand for patient-centred care, mor
Xtalks — The Life Science Community™, Online webinar
  2026-12-14
Microbiology / Virology: Psychedelic therapies are rapidly emerging as one of the most promising areas of innovation in central nervous system (CNS) research, offering potential new treatment approaches for individuals living
Xtalks — The Life Science Community™, Online webinar
  2026-12-15
Others: Decisions made early in the drug development process from preclinical through Phase IIa can disproportionately impact later development as costs increase with each phase. Timely information quantifyin
Xtalks — The Life Science Community™, Online webinar
  2026-12-16
Others: Spatial biology provides a window into not only what is happening within tissue, but where it is happening. By visualizing and quantifying biomarker expression within intact tissue, researchers can ex
Xtalks — The Life Science Community™, Online webinar
  2026-12-16
Microbiology / Virology: Therapeutic innovation is moving beyond conventional small molecules and monoclonal antibodies toward complex modalities that can engage previously inaccessible biology, overcome resistance and improv
Xtalks — The Life Science Community™, Online webinar
  2026-12-17
Microbiology / Virology: In the rapidly evolving landscape of respiratory clinical development, aligning cutting-edge strategies with robust trial design is crucial. Respiratory clinical trials require reliable endpoints that
Xtalks — The Life Science Community™, Online webinar
 
January 2027 2027-01-12
Microbiology / Virology: Real-world data (RWD) is increasingly used to support clinical development, safety evaluation and regulatory evidence generation. However, converting electronic health records, claims and registry dat
Xtalks — The Life Science Community™, Online webinar
 
July 2027 Boston, MA
Gene Therapy: 4th Global Cell and Gene Therapy Summit
United Scientific Group, Four Points by Sheraton Wakefield Boston Hotel & Conference Center
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2026 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.